David A. Siegel Ideaya Biosciences, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 460,600 shares of IDYA stock, worth $8.08 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
460,600
Previous 468,100
1.6%
Holding current value
$8.08 Million
Previous $14.8 Million
20.18%
% of portfolio
0.03%
Previous 0.04%
Shares
18 transactions
Others Institutions Holding IDYA
# of Institutions
213Shares Held
79.9MCall Options Held
39.6KPut Options Held
24.1K-
Black Rock Inc. New York, NY6.81MShares$119 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X05.86MShares$103 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$89.1 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.06MShares$88.8 Million0.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.87MShares$67.8 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $843M
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...